BAJAJFINSV and LICI, both in Life/Health Insurance. Monthly data through 2026-10-12. Change the comparison →
Share price change since May '22, the first month all 2 have a price: BAJAJFINSV +33%, LICI -1%.
Rebased at 2022-05. Monthly closes from each company's history.
Months with a missing value are left as gaps.
The share price return over 3 years, split into net profit growth, share count change and the change in P/E.
BAJAJFINSV: share price rose 10% over 3 years: +55 pts from net profit growth, −38 pts from the P/E change, −8 pts from share count change.
LICI: share price rose 33% over 3 years: +59 pts from net profit growth, −26 pts from the P/E change.
Segments are percentage points of the price return: price = P/E × net profit ÷ share count. These are the same numbers each company's own page shows.
Each cell is the company's percentile rank among its own sector peers that month. Darker is higher-ranked. Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value.
| Metric | BAJAJFINSV | LICI |
|---|---|---|
| Share Price | ₹1719.90 | ₹391.50 |
| Market Cap | ₹5.60L cr | ₹4.95L cr |
| P/E | 27.1x | 8.2x |
| P/B | 7.2x | 2.8x |
| P/S | 3.6x | 0.5x |
| ROCE | 11.0% | 35.0% |
| ROE | 26.5% | 34.0% |
| Operating margin | 41.0% | 6.0% |
| Revenue (TTM), indexed to 100 | ₹1.58L cr | ₹9.94L cr |
| Net Profit (TTM) | ₹20637 cr | ₹60055 cr |
| Debt / Equity | 5.5x | 0.0x |
| Cash Conversion Cycle | 23d | 0d |
| Promoter holding | 58.7% | 96.5% |
| FII Holding | 6.9% | 0.4% |
| DII Holding | 12.1% | 1.0% |
| 12M momentum | -17.6% | -10.4% |
| Drawdown from Peak | -17.9% | -31.9% |
| Cash conversion (3Y) | -2.0x | -0.1x |
| Interest cover | 2.0x | — |
| Share Count Change (1Y) | 0.0% | 0.0% |
| Volatility (1Y) | 24.7% | 26.0% |
Latest month in the data: 2026-10. Highlight marks the higher value, or the lower value for P/E, P/B, P/S, debt, working-capital days, share count change and volatility. It marks a number, not a better investment.
Comparison is descriptive and historical. Highlights mark the higher or lower value on a metric, not a better investment. Not investment advice; ApnaFunda is not a SEBI-registered research analyst.